Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The Histological Features of a Myocardial Biopsy Specimen in a Patient in the Acute Phase of Reversible Catecholamine-induced Cardiomyopathy due to Pheochromocytoma.

Miura M, Kawano H, Yoshida T, Yamagata Y, Nakata T, Koga S, Ikeda S, Kageyama K, Abe K, Maemura K.

Intern Med. 2017;56(6):665-671. doi: 10.2169/internalmedicine.56.7454. Epub 2017 Mar 17.

2.
3.

Toxic effects of glucagon-induced acute lipid mobilization in geese.

Hoak JC, Connor WE, Warner ED.

J Clin Invest. 1968 Dec;47(12):2701-10.

4.

Effect of l-norepinephrine on left ventricular diastolic pressures in man.

Cudkowicz L.

Thorax. 1968 Jan;23(1):63-8. No abstract available.

5.
6.

Metabolic and tissue effects of prolonged catecholamine infusion.

Eltringham WK, Jenny ME, Morgan AP.

Postgrad Med J. 1969 Aug;45(526):545-9. No abstract available.

7.

Pressor agents.

Smith NT.

Calif Med. 1967 Jul;107(1):33-46. Review. No abstract available.

9.

Role of alpha 1-adrenoceptors in norepinephrine-induced cardiomyopathy.

Lee JC, Sponenberg DP.

Am J Pathol. 1985 Nov;121(2):316-21.

10.

Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms.

Jiang JP, Downing SE.

Yale J Biol Med. 1990 Nov-Dec;63(6):581-91. Review.

11.

Formation of myocardial zonal lesions.

Ratliff NB, Kopelman RI, Goldner RD, Cruz PT, Hackel DB.

Am J Pathol. 1975 May;79(2):321-34.

12.

Effects of insulin on experimental catecholamine cardiomyopathy.

Downing SE, Lee JC.

Am J Pathol. 1978 Nov;93(2):339-52.

13.

Ultrastructure of the myocardium after pulmonary embolism. A study in the rat.

Cuénoud HF, Joris I, Majno G.

Am J Pathol. 1978 Aug;92(2):421-58.

Supplemental Content

Support Center